Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
311 | 35831 | 37.1 | 69% |
Classes in level above (level 4) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
0 | 3633673 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//MED |
Classes in level below (level 2) |
ID, lev. below |
Publications | Label for level below |
---|---|---|
339 | 17217 | CHLOROETHYLCLONIDINE//ALPHA1 ADRENOCEPTOR SUBTYPE//BETA3 ADRENOCEPTORS |
1104 | 9294 | ROLIPRAM//PHOSPHODIESTERASE//PDE4 |
1389 | 7650 | RHO KINASE//FASUDIL//CALDESMON |
3851 | 582 | CU GNRH//GRP MED PHARMACOL TOXICOL//GRP GYNAECOL ONCOL |
3861 | 574 | OTILONIUM//OTILONIUM BROMIDE//PREGNENOLONE SUBSTRATE |
3918 | 514 | CICLETANINE//TIROPRAMIDE//MUSANGA CECROPIOIDES |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ROLIPRAM | Author keyword | 215 | 57% | 1% | 252 |
2 | RHO KINASE | Author keyword | 205 | 39% | 1% | 413 |
3 | PHOSPHODIESTERASE | Author keyword | 180 | 33% | 1% | 452 |
4 | FASUDIL | Author keyword | 175 | 65% | 0% | 166 |
5 | CALDESMON | Author keyword | 164 | 67% | 0% | 148 |
6 | PDE4 | Author keyword | 162 | 72% | 0% | 126 |
7 | CHLOROETHYLCLONIDINE | Author keyword | 144 | 91% | 0% | 60 |
8 | ADENYLYL CYCLASE | Author keyword | 137 | 26% | 1% | 457 |
9 | ALPHA1 ADRENOCEPTOR SUBTYPE | Author keyword | 122 | 88% | 0% | 58 |
10 | NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | Journal | 122 | 14% | 2% | 814 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ROLIPRAM | 215 | 57% | 1% | 252 | Search ROLIPRAM | Search ROLIPRAM |
2 | RHO KINASE | 205 | 39% | 1% | 413 | Search RHO+KINASE | Search RHO+KINASE |
3 | PHOSPHODIESTERASE | 180 | 33% | 1% | 452 | Search PHOSPHODIESTERASE | Search PHOSPHODIESTERASE |
4 | FASUDIL | 175 | 65% | 0% | 166 | Search FASUDIL | Search FASUDIL |
5 | CALDESMON | 164 | 67% | 0% | 148 | Search CALDESMON | Search CALDESMON |
6 | PDE4 | 162 | 72% | 0% | 126 | Search PDE4 | Search PDE4 |
7 | CHLOROETHYLCLONIDINE | 144 | 91% | 0% | 60 | Search CHLOROETHYLCLONIDINE | Search CHLOROETHYLCLONIDINE |
8 | ADENYLYL CYCLASE | 137 | 26% | 1% | 457 | Search ADENYLYL+CYCLASE | Search ADENYLYL+CYCLASE |
9 | ALPHA1 ADRENOCEPTOR SUBTYPE | 122 | 88% | 0% | 58 | Search ALPHA1+ADRENOCEPTOR+SUBTYPE | Search ALPHA1+ADRENOCEPTOR+SUBTYPE |
10 | BETA3 ADRENOCEPTORS | 109 | 81% | 0% | 65 | Search BETA3+ADRENOCEPTORS | Search BETA3+ADRENOCEPTORS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CYCLIC NUCLEOTIDE PHOSPHODIESTERASES | 546 | 48% | 2% | 840 |
2 | CAMP SPECIFIC PHOSPHODIESTERASE | 386 | 77% | 1% | 261 |
3 | ALPHA 1 ADRENERGIC RECEPTOR SUBTYPES | 292 | 78% | 1% | 191 |
4 | CA2 SENSITIZATION | 289 | 63% | 1% | 288 |
5 | AMP SPECIFIC PHOSPHODIESTERASE | 261 | 95% | 0% | 89 |
6 | ROLIPRAM | 261 | 66% | 1% | 245 |
7 | ALPHA1 ADRENOCEPTOR SUBTYPES | 239 | 68% | 1% | 211 |
8 | LIGHT CHAIN PHOSPHATASE | 227 | 65% | 1% | 218 |
9 | CHLORETHYLCLONIDINE | 218 | 88% | 0% | 105 |
10 | ATYPICAL BETA ADRENOCEPTORS | 202 | 89% | 0% | 93 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 122 | 14% | 2% | 814 |
2 | JOURNAL OF AUTONOMIC PHARMACOLOGY | 77 | 28% | 1% | 234 |
3 | JOURNAL OF CYCLIC NUCLEOTIDE AND PROTEIN PHOSPHORYLATION RESEARCH | 58 | 57% | 0% | 68 |
4 | BLOOD VESSELS | 36 | 28% | 0% | 111 |
5 | ADVANCES IN CYCLIC NUCLEOTIDE AND PROTEIN PHOSPHORYLATION RESEARCH | 35 | 44% | 0% | 60 |
6 | JOURNAL OF CYCLIC NUCLEOTIDE RESEARCH | 22 | 43% | 0% | 39 |
7 | ADVANCES IN CYCLIC NUCLEOTIDE RESEARCH | 15 | 42% | 0% | 27 |
8 | EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 13 | 11% | 0% | 114 |
9 | ADVANCES IN SECOND MESSENGER AND PHOSPHOPROTEIN RESEARCH | 12 | 25% | 0% | 40 |
10 | GENERAL PHARMACOLOGY | 11 | 10% | 0% | 99 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
G-PROTEINS - TRANSDUCERS OF RECEPTOR-GENERATED SIGNALS | 1987 | 5694 | 164 | 77% |
Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use | 2006 | 698 | 246 | 76% |
Advances in targeting cyclic nucleotide phosphodiesterases | 2014 | 39 | 244 | 68% |
Biochemistry and physiology of cyclic nucleotide Phosphocliesterases: Essential components in cyclic nucleotide signaling | 2007 | 471 | 170 | 69% |
Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: Modulated by G proteins, kinases, and myosin phosphatase | 2003 | 1102 | 410 | 50% |
SIGNAL-TRANSDUCTION AND REGULATION IN SMOOTH-MUSCLE | 1994 | 1408 | 83 | 59% |
INTERNATIONAL UNION OF PHARMACOLOGY NOMENCLATURE OF ADRENOCEPTORS | 1994 | 855 | 104 | 91% |
CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES - FUNCTIONAL IMPLICATIONS OF MULTIPLE ISOFORMS | 1995 | 1275 | 136 | 55% |
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents | 2006 | 399 | 334 | 76% |
Overview of PDEs and their regulation | 2007 | 265 | 168 | 88% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ABT PHARMAZEUT BIOCHEM | 35 | 89% | 0.0% | 16 |
2 | CELLULAR BIOCHEM SECT | 26 | 55% | 0.1% | 33 |
3 | MOL PHARMACOL GRP | 25 | 24% | 0.2% | 89 |
4 | PERINATAL BIOL | 20 | 21% | 0.2% | 83 |
5 | BIOCHEM BIOINFORMAT SCI | 14 | 45% | 0.1% | 24 |
6 | MUSCLE BIOL GRP | 13 | 29% | 0.1% | 39 |
7 | PHARMACOMETR PHARMACOKINET | 13 | 71% | 0.0% | 10 |
8 | CARDIAC SIGNAL TRANSDUCT CELLULAR BIOL | 10 | 73% | 0.0% | 8 |
9 | SMOOTH MUSCLE GRP | 10 | 18% | 0.1% | 51 |
10 | DIABET METAB DIS PROGRAM | 9 | 55% | 0.0% | 12 |
Related classes at same level (level 3) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000004784 | BACTERIORHODOPSIN//PHOTOCYCLE//PHYTOCHROME |
2 | 0.0000004709 | ENDOTHELIN//ENDOTHELIN 1//ENDOTHELIUM |
3 | 0.0000003435 | ATRIAL NATRIURETIC PEPTIDE//NA K ATPASE//OUABAIN |
4 | 0.0000003290 | CAFFEINE//ADENOSINE//MOL RECOGNIT SECT |
5 | 0.0000003166 | NITRIC OXIDE//PEROXYNITRITE//NITRIC OXIDE SYNTHASE |
6 | 0.0000003007 | JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY//TRIMETAZIDINE//ISCHEMIC PRECONDITIONING |
7 | 0.0000002782 | DICTYOSTELIUM//JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY//DICTYOSTELIUM DISCOIDEUM |
8 | 0.0000002692 | CEREBRAL ISCHEMIA//SPREADING DEPRESSION//CITICOLINE |
9 | 0.0000002525 | RYANODINE RECEPTOR//SCORPION TOXINS//JOURNAL OF GENERAL PHYSIOLOGY |
10 | 0.0000002432 | S 100B//S100A4//CALCIUM BINDING PROTEIN |